Latest debt-to-equity ratio

Harvard Bioscience Debt-to-equity ratio

Direct answer

Harvard Bioscience's debt-to-equity ratio is 595.93%.

The verified market snapshot reports 595.93%.
Bullstory displays the reported value and does not estimate missing data.
Market data checked October 20, 2026.

Get free Harvard Bioscience email updates.

Bullstory sends one daily email when new analysis or important company news is available.

Verified data

Debt-to-equity ratio
595.93%

Explore related company data

View Harvard Bioscience's market capitalizationView Harvard Bioscience's price-to-book ratioView Harvard Bioscience's return on equityView Harvard Bioscience's dividend yieldView Harvard Bioscience's 52-week price rangeView Harvard Bioscience's revenue growthView Harvard Bioscience's profit marginView all Harvard Bioscience key metricsReturn to Harvard Bioscience profile